Immune activation in amyloid-β-related angiitis correlates with decreased parenchymal amyloid-β plaque load

Neurodegenerative Diseases

Volumn 13, Issue 1, 2013, Pages 38-44

  Bogner, S ^a   Bernreuther, C ^a   Matschke, J ^a   Barrera Ocampo, A ^a   Sepulveda Falla, D ^a   Leypoldt, F ^b   Magnus, T ^b   Haag, F ^a   Bergmann, M ^c   Bruck W ^d   Vogelgesang, S ^e   Glatzel, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Department of Neurology ^*  (Germany)

^c KLINIKUM BREMEN MITTE   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Amyloid ; Angiitis; Angiopathy; Neuroinflammation; Neuropathology

Indexed keywords

AMYLOID BETA PROTEIN; CD68 ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; AMYLOID BETA RELATED ANGIITIS; AMYLOID PLAQUE; ARTICLE; BRAIN BLOOD VESSEL; BRAIN TISSUE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MIDDLE AGED; PARENCHYMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VASCULAR AMYLOIDOSIS; VASCULITIS; BLOOD VESSEL WALL; BRAIN VASCULITIS; CLEARANCE; GRANULOMATOSIS; MICROGLIA; NEUROIMAGING; NEUROPIL THREAD;

AGED; AMYLOID BETA-PEPTIDES; BRAIN; CASE-CONTROL STUDIES; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MIDDLE AGED; PLAQUE, AMYLOID; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 84891071010     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000352020     Document Type: Article

References (33)

1. Miller DV, Salvarani C, Hunder GG, Brown RD, Parisi JE, Christianson TJ, Giannini C: Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol 2009; 33: 35-43.
2. Biffi A, Greenberg SM: Cerebral amyloid angiopathy: a systematic review. J Clin Neurol 2011; 7: 1-9.
3. Vinters HV, Gilbert JJ: Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983; 14: 924-928. (Pubitemid 14205243)
4. Rigby H, Easton A, Bhan V: Amyloid-β-related angiitis of the central nervous system: report of 3 cases. Can J Neurol Sci 2011; 38: 626-630.
5. Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, MacKenzie JM, Xuereb JH, Love S: Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 2005; 128: 500-515. (Pubitemid 40380186)
6. Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM: Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004; 55: 250-256. (Pubitemid 38167002)
7. Fountain NB, Eberhard DA: Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature. Neurology 1996; 46: 190-197. (Pubitemid 26156128)
8. Schwab P, Lidov HG, Schwartz RB, Anderson RJ: Cerebral amyloid angiopathy associated with primary angiitis of the central nervous system: report of 2 cases and review of the literature. Arthritis Rheum 2003; 49: 421-427. (Pubitemid 36682411)
9. Chung KK, Anderson NE, Hutchinson D, Synek B, Barber PA: Cerebral amyloid angiopathy related inflammation: three case reports and a review. J Neurol Neurosurg Psychiatry 2011; 82: 20-26.
10. Mandybur TI, Balko G: Cerebral amyloid angiopathy with granulomatous angiitis ameliorated by steroid-Cytoxan treatment. Clin Neuropharmacol 1992; 15: 241-247.
11. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J, Meschia JF, Giannini C, Miller DV, Hunder GG: Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology (Oxford) 2008; 47: 1671-1677.
12. Salvarani C, Brown RD Jr, Hunder GG: Adult primary central nervous system vasculitis: an update. Curr Opin Rheumatol 2012; 24: 46-52.
13. Kellner A, Matschke J, Bernreuther C, Moch H, Ferrer I, Glatzel M: Autoantibodies against β-amyloid are common in Alzheimer's disease and help control plaque burden. Ann Neurol 2009; 65: 24-31.
14. Streit WJ: Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history. Front Aging Neurosci 2010; 2: 22.
15. Reid AH, Maloney AF: Giant cell arteritis and arteriolitis associated with amyloid angiopathy in an elderly mongol. Acta Neuropathol 1974; 27: 131-137.
16. Yamada M, Itoh Y, Shintaku M, Kawamura J, Jensson O, Thorsteinsson L, Suematsu N, Matsushita M, Otomo E: Immune reactions associated with cerebral amyloid angiopathy. Stroke 1996; 27: 1155-1162. (Pubitemid 26226947)
17. DiFrancesco JC, Brioschi M, Brighina L, Ruffmann C, Saracchi E, Costantino G, Galimberti G, Conti E, Curto NA, Marzorati L, Remida P, Tagliavini F, Savoiardo M, Ferrarese C: Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology 2011; 76: 842-844.
18. Hermann DM, Keyvani K, van de Nes J, Weimar C, Wiltfang J, Nitsch RM, Szodorai A: Brain-reactive β-amyloid antibodies in primary CNS angiitis with cerebral amyloid angiopathy. Neurology 2011; 77: 503-505.
19. Winkler DT, Bondolfi L, Herzig MC, Jann L, Calhoun ME, Wiederhold KH, Tolnay M, Staufenbiel M, Jucker M: Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci 2001; 21: 1619-1627. (Pubitemid 32182202)
20. Hock C, Konietzko U, Streffer JR, Tracy J, Signorell A, Muller-Tillmanns B, Lemke U, Henke K, Moritz E, Garcia E, Wollmer MA, Umbricht D, de Quervain DJ, Hofmann M, Maddalena A, Papassotiropoulos A, Nitsch RM: Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease. Neuron 2003; 38: 547-554. (Pubitemid 36645030)
21. Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO: Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat Med 2003; 9: 448-452. (Pubitemid 36460079)
22. Ferrer I, Boada Rovira M, Sanchez Guerra ML, Rey MJ, Costa-Jussa F: Neuropathology and pathogenesis of encephalitis following amyloid-β immunization in Alzheimer's disease. Brain Pathol 2004; 14: 11-20. (Pubitemid 38200585)
23. Koller MF, Mohajeri MH, Huber M, Wollmer MA, Roth Z'graggen B V, Sandmeier E, Moritz E, Tracy J, Nitsch RM, Christen P: Active immunization of mice with an Aβ-Hsp70 vaccine. Neurodegener Dis 2004; 1: 20-28. (Pubitemid 38581675)
24. Keage HA, Carare RO, Friedland RP, Ince PG, Love S, Nicoll JA, Wharton SB, Weller RO, Brayne C: Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol 2009; 9: 3.
25. Glatzel M, Ott PM, Linder T, Gebbers JO, Gmur A, Wust W, Huber G, Moch H, Podvinec M, Stamm B, Aguzzi A: Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol 2003; 2: 757-763. (Pubitemid 37443518)
26. Weidemann A, Konig G, Bunke D, Fischer P, Salbaum JM, Masters CL, Beyreuther K: Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989; 57: 115-126. (Pubitemid 19098873)
27. Sepulveda-Falla D, Matschke J, Bernreuther C, Hagel C, Puig B, Villegas A, Garcia G, Zea J, Gomez-Mancilla B, Ferrer I, Lopera F, Glatzel M: Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease. Brain Pathol 2011; 21: 452-463.
28. Melzer N, Harder A, Gross CC, Wolfer J, Stummer W, Niederstadt T, Meuth SG, Marziniak M, Grauer OM, Wiendl H: CD4+ T cells predominate in cerebrospinal fluid and leptomeningeal and parenchymal infiltrates in cerebral amyloid-β-related angiitis. Arch Neurol 2012; 69: 773-777.
29. Kurian M, Burkhardt K, Assal F, Kovari E, Horvath J: Amyloid plaques and intraneuronal tau inclusions in Aβ-related angiitis (ABRA). Neuropathol Appl Neurobiol 2012; 38: 391-394.
30. Nicoll JA, Barton E, Boche D, Neal JW, Ferrer I, Thompson P, Vlachouli C, Wilkinson D, Bayer A, Games D, Seubert P, Schenk D, Holmes C: Aβ species removal after Aβ42 immunization. J Neuropathol Exp Neurol 2006; 65: 1040-1048.
31. Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JA: Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain. Brain 2008; 131: 3299-3310.
32. Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Lieberburg I, Arrighi HM, Morris KA, Lu Y, Liu E, Gregg KM, Brashear HR, Kinney GG, Black R, Grundman M: Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol 2012; 11: 241-249.
33. Piazza F, Greenberg SM, Savoiardo M, Gardinetti M, Chiapparini L, Raicher I, Nitrini R, Sakaguchi H, Brioschi M, Billo G, Colombo A, Lanzani F, Piscosquito G, Carriero MR, Giaccone G, Tagliavini F, Ferrarese C, Difrancesco JC: Anti-amyloid-β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol, E-pub ahead of print.